Screenshot 2024-02-12 at 11.24.12 AM

Can Viagra lower the risk of Alzheimer disease in men? Here is what the new study shows

Produced by: Tarun Mishra Designed by: Manoj Kumar

image
Screenshot 2024-02-12 at 11.22.10 AM

Erectile Dysfunction Drugs

A recent study suggests that medications commonly used for treating erectile dysfunction could potentially lower the risk of developing Alzheimer's disease.

Screenshot 2024-02-12 at 11.27.49 AM

The Link

Men prescribed drugs like Viagra showed an 18% lower likelihood of developing Alzheimer's later in life compared to those not taking such medication, according to research published in journal Neurology.

AdobeStock_421239213

Association vs. Causation

While the study found an association between these drugs and reduced Alzheimer's risk, it does not conclusively prove that the drugs directly prevent the disease.

Screenshot 2024-02-12 at 11.39.16 AM

Need for Further Investigation

Lead author of the study, Dr. Ruth Brauer, emphasized the need for clinical trials to ascertain the true impact of these drugs on Alzheimer's risk, urging studies involving both men and women.

Screenshot 2024-02-12 at 11.41.16 AM

Study Details

The study examined over 2,60,000 men with erectile dysfunction but no memory issues, tracking their medical records for five years to monitor Alzheimer's cases.

Commonly Used Drugs

More than half of the participants were taking drugs known as PDE5 inhibitors, including sildenafil (Viagra), avanafil, vardenafil, and tadalafil.

Screenshot 2024-02-12 at 11.40.16 AM
Screenshot 2024-02-12 at 11.42.17 AM

Mechanism of Action

These drugs target a substance called beta amyloid, believed to contribute to Alzheimer's development by accumulating in the brain.

Screenshot 2024-02-12 at 11.44.09 AM

Potential Treatment Implications

Researchers speculate that understanding how these drugs affect beta amyloid accumulation could lead to new approaches in Alzheimer's treatment.

Screenshot 2024-02-12 at 12.17.43 PM

Call for Further Research

While the study provides promising insights, experts stress the need for additional rigorous research to fully understand the impact of these drugs on brain health and Alzheimer's disease.